Gocl [GOCLCORP] vs Kingfa Science [KINGFA] Detailed Stock Comparison
Gocl
NSE
Loading...
Kingfa Science
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Gocl wins in 7 metrics, Kingfa Science wins in 11 metrics, with 0 ties. Kingfa Science appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Gocl | Kingfa Science | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 19.09 | 30.12 | Gocl |
| Price-to-Book Ratio | 1.12 | 6.35 | Gocl |
| Debt-to-Equity Ratio | 70.75 | 5.90 | Kingfa Science |
| PEG Ratio | N/A | 16.19 | N/A |
| EV/EBITDA | 10.50 | 20.76 | Gocl |
| Profit Margin (TTM) | 259.04% | 8.58% | Gocl |
| Operating Margin (TTM) | 88.52% | 11.17% | Gocl |
| EBITDA Margin (TTM) | 88.52% | 11.17% | Gocl |
| Return on Equity | 9.97% | 20.98% | Kingfa Science |
| Return on Assets (TTM) | 5.06% | 13.23% | Kingfa Science |
| Free Cash Flow (TTM) | $9.30M | $295.94M | Kingfa Science |
| Dividend Yield | 3.55% | 0.32% | Gocl |
| 1-Year Return | -18.72% | 31.52% | Kingfa Science |
| Price-to-Sales Ratio (TTM) | 3.41 | 2.58 | Kingfa Science |
| Enterprise Value | $28.63B | $46.42B | Kingfa Science |
| EV/Revenue Ratio | 5.16 | 2.59 | Kingfa Science |
| Gross Profit Margin (TTM) | 19.86% | 22.30% | Kingfa Science |
| Revenue per Share (TTM) | $105 | $1,478 | Kingfa Science |
| Earnings per Share (Diluted) | $18.71 | $126.75 | Kingfa Science |
| Beta (Stock Volatility) | N/A | 0.66 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Gocl vs Kingfa Science Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Gocl | -0.25% | 5.03% | -9.49% | 23.89% | 11.30% | -4.51% |
| Kingfa Science | 8.58% | 9.13% | 12.07% | 18.51% | 37.66% | 11.62% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Gocl | -18.72% | 22.19% | 95.03% | 143.92% | 308.11% | 52.89% |
| Kingfa Science | 31.52% | 278.86% | 672.29% | 1,316.36% | 10,861.24% | 12,694.24% |
Performance & Financial Health Analysis: Gocl vs Kingfa Science
| Metric | GOCLCORP | KINGFA |
|---|---|---|
| Market Information | ||
| Market Cap | ₹17.70B | ₹46.24B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 76,862 | 17,014 |
| 90 Day Avg. Volume | 102,275 | 14,157 |
| Last Close | ₹356.20 | ₹4,145.30 |
| 52 Week Range | ₹245.00 - ₹516.80 | ₹2,550.00 - ₹4,190.00 |
| % from 52W High | -31.08% | -1.07% |
| All-Time High | ₹699.55 (Jan 22, 2018) | ₹4,190.00 (Aug 18, 2025) |
| % from All-Time High | -49.08% | -1.07% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.50% | 0.11% |
| Quarterly Earnings Growth | 32.73% | 0.02% |
| Financial Health | ||
| Profit Margin (TTM) | 2.59% | 0.09% |
| Operating Margin (TTM) | 0.89% | 0.11% |
| Return on Equity (TTM) | 0.10% | 0.21% |
| Debt to Equity (MRQ) | 70.75 | 5.90 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹318.00 | ₹601.64 |
| Cash per Share (MRQ) | N/A | ₹19.54 |
| Operating Cash Flow (TTM) | ₹1.85B | ₹993.76M |
| Levered Free Cash Flow (TTM) | ₹1.57B | ₹1.53B |
| Dividends | ||
| Last 12-Month Dividend Yield | 3.55% | 0.32% |
| Last 12-Month Dividend | ₹14.00 | ₹10.00 |
Valuation & Enterprise Metrics Analysis: Gocl vs Kingfa Science
| Metric | GOCLCORP | KINGFA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 19.09 | 30.12 |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | 16.19 |
| Price to Sales (TTM) | 3.41 | 2.58 |
| Price to Book (MRQ) | 1.12 | 6.35 |
| Market Capitalization | ||
| Market Capitalization | ₹17.70B | ₹46.24B |
| Enterprise Value | ₹28.63B | ₹46.42B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.16 | 2.59 |
| Enterprise to EBITDA | 10.50 | 20.76 |
| Risk & Other Metrics | ||
| Beta | N/A | 0.66 |
| Book Value per Share (MRQ) | ₹318.00 | ₹601.64 |
Financial Statements Comparison: Gocl vs Kingfa Science
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | GOCLCORP | KINGFA |
|---|---|---|
| Revenue/Sales | ₹1.14B | ₹4.70B |
| Cost of Goods Sold | ₹917.01M | ₹3.63B |
| Gross Profit | ₹227.28M | ₹1.07B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹500.82M | ₹905.70M |
| EBITDA | ₹-280.76M | ₹623.82M |
| Pre-Tax Income | ₹-466.89M | ₹543.29M |
| Income Tax | ₹-53.51M | ₹124.31M |
| Net Income (Profit) | ₹231.19M | ₹418.98M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | GOCLCORP | KINGFA |
|---|---|---|
| Cash & Equivalents | ₹222.72M | ₹234.80M |
| Total Current Assets | ₹18.67B | ₹8.54B |
| Total Current Liabilities | ₹4.19B | ₹4.22B |
| Long-Term Debt | ₹10.13B | ₹20.61M |
| Total Shareholders Equity | ₹15.76B | ₹7.29B |
| Retained Earnings | N/A | ₹4.55B |
| Property, Plant & Equipment | ₹586.64M | ₹2.44B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | GOCLCORP | KINGFA |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | GOCLCORP | KINGFA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 76,862 | 17,014 |
| Average Daily Volume (90 Day) | 102,275 | 14,157 |
| Shares Outstanding | 49.57M | 12.11M |
| Float Shares | 11.63M | 1.66M |
| % Held by Insiders | 0.75% | 0.86% |
| % Held by Institutions | 0.01% | 0.00% |
Dividend Analysis & Yield Comparison: Gocl vs Kingfa Science
| Metric | GOCLCORP | KINGFA |
|---|---|---|
| Last 12-Month Dividend | ₹14.00 | ₹10.00 |
| Last 12-Month Dividend Yield | 3.55% | 0.32% |
| 3-Year Avg Annual Dividend | ₹6.33 | ₹3.33 |
| 3-Year Avg Dividend Yield | 1.59% | 0.30% |
| 3-Year Total Dividends | ₹19.00 | ₹10.00 |
| Ex-Dividend Date | Jul 25, 2025 | Sep 17, 2024 |